Dialogue Health Technologies Inc.
DLHTF · OTC
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Revenue | $25,539 | $24,532 | $19,794 | $23,614 |
| % Growth | 4.1% | 23.9% | -16.2% | – |
| Cost of Goods Sold | $10,294 | $10,456 | $8,974 | $11,295 |
| Gross Profit | $15,245 | $14,076 | $10,820 | $12,319 |
| % Margin | 59.7% | 57.4% | 54.7% | 52.2% |
| R&D Expenses | $3,658 | $3,158 | $2,697 | $2,799 |
| G&A Expenses | $12,861 | $9,663 | $8,250 | $13,174 |
| SG&A Expenses | $16,925 | $14,069 | $11,472 | $16,290 |
| Sales & Mktg Exp. | $4,064 | $4,406 | $3,222 | $3,116 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $20,583 | $17,227 | $14,169 | $19,089 |
| Operating Income | -$5,338 | -$3,151 | -$3,349 | -$6,770 |
| % Margin | -20.9% | -12.8% | -16.9% | -28.7% |
| Other Income/Exp. Net | $518 | $502 | -$920 | $276 |
| Pre-Tax Income | -$4,820 | -$2,649 | -$4,269 | -$6,494 |
| Tax Expense | $937 | $6 | $238 | -$502 |
| Net Income | -$5,757 | -$2,655 | -$4,507 | -$5,992 |
| % Margin | -22.5% | -10.8% | -22.8% | -25.4% |
| EPS | -0.086 | -0.04 | -0.068 | -0.091 |
| % Growth | -115.6% | 41.3% | 25.1% | – |
| EPS Diluted | -0.086 | -0.04 | -0.068 | -0.091 |
| Weighted Avg Shares Out | 67,067 | 66,720 | 66,428 | 66,235 |
| Weighted Avg Shares Out Dil | 67,067 | 66,720 | 66,428 | 66,235 |
| Supplemental Information | – | – | – | – |
| Interest Income | $560 | $548 | $588 | $343 |
| Interest Expense | $25 | $27 | $35 | $27 |
| Depreciation & Amortization | $784 | $753 | $947 | $944 |
| EBITDA | -$4,011 | -$1,869 | -$1,843 | -$5,523 |
| % Margin | -15.7% | -7.6% | -9.3% | -23.4% |